Dopaminergic inhibition of striatal cholinergic neurons: synergistic blocking action of gamma-butyrolactone and neuroleptic drugs.
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D002087:Butyrates / Q000494:pharmacology*; D002250:Carbon Radioisotopes; D002415:Cats; D002421:Caudate Nucleus / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects*; D003984:Dibenzazepines / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004357:Drug Synergism; D005260:Female; D005663:Furans / Q000494:pharmacology*; D007783:Lactones / Q000494:pharmacology; D008297:Male; D009474:Neurons / Q000187:drug effects*; D010879:Piperazines / Q000494:pharmacology; D013238:Stereotaxic Techniques; D009435:Synaptic Transmission / Q000187:drug effects; D014149:Tranquilizing Agents / Q000494:pharmacology*
D002087:Butyrates; D002250:Carbon Radioisotopes; D003984:Dibenzazepines; D005663:Furans; D007783:Lactones; D010879:Piperazines; D014149:Tranquilizing Agents; D000109:Acetylcholine; D002746:Chlorpromazine; D004298:Dopamine